Drug discontinuation: Scopolamine Transdermal System (SCOPOLAMINE TRANSDERMAL SYSTEM)
FDA lists 1 presentation as To Be Discontinued. Companies: Padagis US LLC.
- Published by source
- 2025-11-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Padagis US LLC
- Products
- Scopolamine Transdermal System SCOPOLAMINE TRANSDERMAL SYSTEM
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2025-11-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1026 | new | 2026-10-22 | 33363cdf660e…2bfc93 | 95505593a2b2…c1cdf4 |
Chain head: #1094 edf3be25ec2e…478842